Business Description
Newbury Pharmaceuticals AB
ISIN : SE0015244884
Compare
Compare
Traded in other countries / regions
NEWBRY.SwedenP52.Germany IPO Date
2022-02-07Description
Newbury Pharmaceuticals AB is a hybrid pharmaceutical company for specialty prescription drugs, innovation and brands with focus on the Scandinavian markets.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.49 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 0.7 | |||||
| Beneish M-Score | -0.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 57.05 | |||||
| 9-Day RSI | 50.58 | |||||
| 14-Day RSI | 46.47 | |||||
| 6-1 Month Momentum % | -19.35 | |||||
| 12-1 Month Momentum % | -22.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.13 | |||||
| Quick Ratio | 0.93 | |||||
| Cash Ratio | 0.2 | |||||
| Days Inventory | 92.14 | |||||
| Days Sales Outstanding | 145.84 | |||||
| Days Payable | 117.39 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 41.73 | |||||
| Operating Margin % | -62.61 | |||||
| Net Margin % | -75.93 | |||||
| FCF Margin % | -113.7 | |||||
| ROE % | -34.87 | |||||
| ROA % | -21.48 | |||||
| ROIC % | -21.45 | |||||
| ROCE % | -25.4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.6 | |||||
| PB Ratio | 1.46 | |||||
| EV-to-EBIT | -4.07 | |||||
| EV-to-EBITDA | -4.46 | |||||
| EV-to-Revenue | 2.94 | |||||
| EV-to-FCF | -2.61 | |||||
| Earnings Yield (Greenblatt) % | -24.59 | |||||
| FCF Yield % | -35.1 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Newbury Pharmaceuticals AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 1.986 | ||
| EPS (TTM) (€) | -0.078 | ||
| Beta | 0 | ||
| Volatility % | 92.35 | ||
| 14-Day RSI | 46.47 | ||
| 14-Day ATR (€) | 0.010259 | ||
| 20-Day SMA (€) | 0.194875 | ||
| 12-1 Month Momentum % | -22.18 | ||
| 52-Week Range (€) | 0.172 - 0.435 | ||
| Shares Outstanding (Mil) | 24.26 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Newbury Pharmaceuticals AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Newbury Pharmaceuticals AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Newbury Pharmaceuticals AB Frequently Asked Questions
What is Newbury Pharmaceuticals AB(FRA:P52)'s stock price today?
The current price of FRA:P52 is €0.20. The 52 week high of FRA:P52 is €0.44 and 52 week low is €0.17.
When is next earnings date of Newbury Pharmaceuticals AB(FRA:P52)?
The next earnings date of Newbury Pharmaceuticals AB(FRA:P52) is 2024-07-10.
Does Newbury Pharmaceuticals AB(FRA:P52) pay dividends? If so, how much?
Newbury Pharmaceuticals AB(FRA:P52) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers